We are live on ! Find out more
HL

Harding Loevner Portfolio holdings

AUM $10.6B
1-Year Est. Return 19.39%
This Fund
S&P 500
This Quarter Est. Return
-1.92%
1 Year Est. Return
+19.39%
3 Year Est. Return
+79.14%
5 Year Est. Return
+100.61%
10 Year Est. Return
+428.16%
AUM
$15.3B
AUM Growth
-$956M
Cap. Flow
-$431M
Cap. Flow %
-2.83%
Top 10 Hldgs %
38.03%
Holding
163
New
10
Increased
23
Reduced
75
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 22.43%
2 Technology 20.31%
3 Healthcare 16.41%
4 Industrials 9.2%
5 Communication Services 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLB icon
76
Core Laboratories
CLB
$575M
$1.66M 0.01%
123,222
+7,543
+7% +$127K
EFG icon
77
iShares MSCI EAFE Growth ETF
EFG
$17B
$1.43M 0.01%
+19,760
New +$1.61M
CHKP icon
78
Check Point Software Technologies
CHKP
$14B
$880K 0.01%
7,853
-8,530
-52% -$1.03M
EFA icon
79
iShares MSCI EAFE ETF
EFA
$80.1B
$393K ﹤0.01%
7,011
-3,290
-32% -$205K
DEO icon
80
Diageo
DEO
$49.6B
$280K ﹤0.01%
1,646
-294,492
-99% -$52.8M
XOM icon
81
ExxonMobil
XOM
$656B
$171K ﹤0.01%
+1,955
New +$178K
BNTX icon
82
BioNTech
BNTX
$26.1B
$162K ﹤0.01%
1,202
NTES icon
83
NetEase
NTES
$76.4B
$115K ﹤0.01%
1,521
+97
+7% +$8.53K
SAN icon
84
Banco Santander
SAN
$217B
$114K ﹤0.01%
49,212
VT icon
85
Vanguard Total World Stock ETF
VT
$82.5B
$94K ﹤0.01%
1,190
-3,780
-76% -$332K
ACWX icon
86
iShares MSCI ACWI ex US ETF
ACWX
$12.7B
$86K ﹤0.01%
2,150
-998,553
-100% -$44.4M
IT icon
87
Gartner
IT
$11.8B
$86K ﹤0.01%
311
ABBV icon
88
AbbVie
ABBV
$453B
$85K ﹤0.01%
637
RGA icon
89
Reinsurance Group of America
RGA
$16.5B
$84K ﹤0.01%
671
NBIX icon
90
Neurocrine Biosciences
NBIX
$15.8B
$81K ﹤0.01%
767
-43
-5% -$4.36K
BWA icon
91
BorgWarner
BWA
$13.8B
$80K ﹤0.01%
2,890
BMY icon
92
Bristol-Myers Squibb
BMY
$136B
$77K ﹤0.01%
1,086
SBNY
93
DELISTED
Signature Bank
SBNY
$71K ﹤0.01%
471
+258
+121% +$46.9K
RYAAY icon
94
Ryanair
RYAAY
$28.7B
$67K ﹤0.01%
2,858
+1,430
+100% +$40.3K
MRK icon
95
Merck
MRK
$371B
$63K ﹤0.01%
734
JPM icon
96
JPMorgan Chase
JPM
$953B
$62K ﹤0.01%
589
HEI icon
97
HEICO Corp
HEI
$45.5B
$60K ﹤0.01%
419
UL icon
98
Unilever
UL
$138B
$50K ﹤0.01%
+1,020
New +$53.3K
SBUX icon
99
Starbucks
SBUX
$119B
$49K ﹤0.01%
578
TER icon
100
Teradyne
TER
$55.8B
$46K ﹤0.01%
618

Similar funds

Harding Loevner's Q3 2022 Portfolio in Review

As of Q3 2022, Harding Loevner held 163 positions worth $15.3B, down 5.9% from $16.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Harding Loevner's Q3 2022 filing shows 10 new, 23 increased, 75 reduced and 1 closed positions. Its largest new stake was iShares MSCI EAFE Growth ETF: 19,760 shares worth $1.43M. The largest sale was UnitedHealth, an estimated $81.5M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

  • Harding Loevner's largest Q3 2022 buy was iShares MSCI EAFE Growth ETF: 19,760 shares worth $1.43M.
  • Harding Loevner added most to Meta Platforms (Facebook) in Q3 2022, an estimated $261M increase.
  • Harding Loevner's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $81.5M.
  • Harding Loevner fully exited Domino's in Q3 2022, selling an estimated $16K.
  • Harding Loevner's ten largest holdings make up 38% of its $15.3B portfolio in Q3 2022.
  • Harding Loevner opened 10 new positions and closed 1 in Q3 2022.
  • Harding Loevner's portfolio value fell 5.9% quarter-over-quarter to $15.3B.

Based on Harding Loevner's 13F filing for Q3 2022, filed 14 Nov 2022.